CTP Inhibitors

Drug / Medication

A class of drugs designed to raise HDL cholesterol; trials have largely failed to improve outcomes, supporting the idea that HDL manipulation is not causally linked to reduced cardiovascular events.

Mentioned in 2 videos

Videos Mentioning CTP Inhibitors

Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast

Cardiovascular disease & why we should change the way we assess risk | The Peter Attia Drive Podcast

Peter Attia MD

A class of drugs that proved manipulating HDL cholesterol does not change cardiovascular outcomes, providing evidence that HDL is not causal.

229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB

229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB

Peter Attia MD

A class of drugs designed to raise HDL cholesterol; trials have largely failed to improve outcomes, supporting the idea that HDL manipulation is not causally linked to reduced cardiovascular events.